Galectin Therapeutics
GALT
GALT
70 hedge funds and large institutions have $28.2M invested in Galectin Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
Holders
70
Holding in Top 10
–
Calls
$2.84M
Puts
$1.23M
Top Buyers
| 1 | +$511K | |
| 2 | +$388K | |
| 3 | +$164K | |
| 4 |
QAM
QCI Asset Management
Pittsford,
New York
|
+$116K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$95K |
Top Sellers
| 1 | -$1.39M | |
| 2 | -$847K | |
| 3 | -$316K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$152K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$136K |